790 Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+myeloid dendritic cells plus ipilimumab and AS01Bin combination with intravenously administered nivolumab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.